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RESUMEN
Uso de residuos sólidos a partir de la industria del olivo
La investigación de nuevos aprovechamientos del olivar y
en particular de lo subproductos del proceso de producción
del aceite, tiene gran relevancia tanto en la economía como en
el medio ambiente de los pueblos donde se desarrolla este
cultivo. Son numerosos los trabajos publicados sobre la com-
posición química de la aceituna y el aceite de oliva, en cam-
bio sólo existen algunos estudios sobre el aislamiento e iden-
tificación de los compuestos de la hoja de olivo, en esta
contribución se revisan los conocimientos sobre la composi-
ción química de la hoja de olivo, así como, las utilizaciones de
los residuos sólidos -hoja de olivo y hueso de aceituna- que
se originan en la producción del aceite de oliva y de aceitunas
de mesa, como energía renovable y para la obtención de com-
puestos de alto valor añadido. Estos últimos, compuestos
bioactivos dirigidos a los mercados de los aditivos alimenta-
rios naturales, farmacéutico y cosmético, todos ellos muy re-
ceptivos en la actualidad a los productos de origen natural.
PALABRAS-CLAVE: Aprovechamiento de subproductos
- Biomasa del olivar - Compuestos bioactivos - Hoja de olivo
- Residuo sólido.
SUMMARY
Use of solid residue from the olive industry
Research into finding new uses for olive products,
particularly by-products of olive oil production, is of great
relevance not only to the economy, but also to the environment,
in the towns where olives are grown. A large number of
research articles has been published dealing with the chemical
composition of olives and olive oil; however, only a few studies
have centered on isolating and identifying compounds in the
olive leaf. In this article an overview of the present body of
knowledge on the chemical composition of the olive leaf will be
presented. Also to be discussed is the use of solid residue,
namely, the olive leaf and the olive stone. Both of these types
of residue result from olive oil and table olive production, and
can be used as a renewable energy source, as well as to obtain
high added-value compounds. The latter, bioactive compounds
are directed towards the cosmetic, pharmaceutical, and natural
food supplements markets, all of which are currently highly
receptive to products of natural origin
KEY-WORDS: Bioactive compounds - Olive biomass -
Olive leaf - Solid residue - Use of by-products.
1. INTRODUCTION
Olive tree cultivation in the Mediterranean goes
back to ancient times, ever since the Roman Age
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(Melillo, 1994), when olive cultivation spread
throughout the entire Mediterranean basin. This
longevous tree (Olea europaea, Oleaceae)
integrates and identifies economically, socially, and
culturally the inhabitants of this basin; olive oil
constitutes the main source of nutritional fats and is
a very valuable product for exportation. Today,
Mediterranean countries account for around 98% of
the world's olive cultivation (approximately ten
million hectares); they produce about 1,9 million
metric tonnes per annum of olive oil, in addition to
1,1 million t of table olives (mean production during
the four-season reference period from 1999/00 to
2002/03, http://www.internationaloliveoil.org/ ).
The use of solid residue, such as leaves and
stones, is of great economic and social importance
for the Mediterranean area, as these by-products
accumulate in large amounts during olive oil
production and the elaboration of table olives.
At present, it is possible to obtain activated
carbon from olive stones (Rivera-Utrilla et al., 1986;
Galiatsatou et al., 2001; Feng-Chin and Ru-Ling,
2000; Khalil et al., 2001; Blázquez et al., 2005), and
the new biomass boiler system designs facilitate the
use of olive stones as fuel for the generation of heat
and electricity (Ortega-Jurado et al., 2004;
Vlyssides et al., 2004). However, olive leaves, which
are produced in large amounts, render scarce
profits at present. Nevertheless, the market for
natural ingredients and additives is rapidly growing,
with such products obtaining high prices.
In the last few years, the possible toxicity of
synthetic compounds (Fukushima and Tsuda,
1985; Fukushima et al., 1986; Stone, 2003), has
increased interest in natural products and the food
additives, cosmetics and pharmaceutical industries
have improved their efforts in preparing bioactive
compounds from natural products by extraction,
fractionation, and purification.
2. BIOACTIVE COMPOUNDS IN OLIVE LEAVES
Olive leaves are agricultural residue resulting
from the pruning of olive trees. The leaves may also
be considered an easily available industrial by-
product, as they find their way to the olive mills in
appreciable quantities. Olive leaves represent
around 10% of the total weight of olives arriving to
the mill (Espínola, 1996). Currently this by-product
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is not very profitable, given that in many countries
the leaves have traditionally been used only as feed
for livestock (Gómez-Cabrera et al., 1992; Sánchez
et al., 2002; Ruíz et al., 2004). Often the leaves are
disposed of by simply burning them together with
the branches from pruning.
2.1. Phenolic Components 
The leaves of Olea europaea L. have been
studied, among other reasons, for their therapeutic
effects. Interest in the potential health benefits of
olive leaf extract dates back to the mid-nineteenth
century, when reports were made of the ability of an
extract (made from boiling the leaves) to reduce
fever, including the ability to prevent or cure malaria
symptoms even more effectively than quinine
(Hanbury, 1854; Capretti and Bonaconza, 1949).
This singular physiological effect also encouraged
identification of the principal agent involved. In the
early 20th century, the phenolic compound which is
most abundant and characteristic in the fruit of the
olive was isolated by Bourquelot and Vintilesco
(1908). In 1960 Panizzi et al. established that the
compound was a heterosidic ester of elenolic acid
and hydroxytyrosol. Oleuropein is the principal
member of the family of secoiridoids in the olive tree
(Olea europaea L.). In 1974, Inouye et al. confirmed
its structure by mass spectrometry.
For over thirty years since the isolation of
oleuropein, extracts from various parts of the olive
tree have been studied. The glucoside has been
found in all of them: leaves, shoots, olive (pulp, husk
and stone), wood, bark and roots (Pasquale et al.,
1991; Juven, 1968). Le Tutour and Guedon (1992)
point out that oleuropein content in olive leaves is very
high, around 60-90 mg per gram (dry material),
although they also contain other compounds.Through
hydrolysis, other phenolic compounds have been
isolated and identified in olive leaves, although they
are present in lesser quantity. These compounds
include demethyloleuropein, ligstroside (Ragazzi et
al., 1973), verbascoside (Fleuriet et al., 1984; Soler-
Rivas et al., 2000) oleoside dimethylester (Panizzi et
al. 1960), a non-glucosidic secoiridoid (Gariboldi et
al., 1986), and oleuroside, an isomer of oleuropein
(Kuwajima et al., 1988).
Additionally, olive leaves contain a significant
amount of flavonoids. Found in the leaf are luteolin-
7-O-glucoside, luteolin-7-O-rutinoside, apigenin-7-
O-glucoside, rutin, luteolin, and apigenin, all of
which have been identified by HPLC (De Laurentis,
1997; Ficarra and Ficarra 1991; Heimler et al.,
2002). The purpose of this group of phenolic
compounds present in the olive leaf seems to be, by
virtue of their absorption spectrum, that of limiting
the effects of UV light and the entailing oxidative
damage (Galli and Visioli, 1999). Flavonoids also
have the capacity to inhibit oxidation caused by free
radicals (Bors et al., 1990 a and b).
The complexity of the chromatographic profiles of
the fraction extracted with polar solvents from the
olive leaf clearly indicates the presence of other
phenolic derivatives, which may be present in the
natural matrix. On the other hand, it can not be ruled
out that the procedures of extraction and treatments
of the sample may alter the structure of some of the
secondary metabolites originally present in the plant
tissue.Therefore, the need exists for the development
of reliable methods for the analysis of the alcoholic
extract of the leaf, prior to any stage of purification. De
Nino et al. (1997) employ a method of direct analysis
of the leaf extract, whose objective is the direct
characterization of metabolites of the olive leaf using
mass spectrometry (MS). This methodology would
permit the “chemical characterization” of a particular
variety, or the identification of compounds of great
biological value.
Among the group of phenolic compounds
present in the olive leaf, oleuropein and the
products of its hydrolysis are those of the greatest
biological interest (Fleming et al., 1973).
Oleuropein has a vasodilator effect, increases
blood flow in the coronary arteries and improves
arrhythmia (Zarzuelo et al., 1991; Manna et al.,
2004). This compound has proven to be a potent
antioxidant with anti-inflammatory properties (Visioli
and Galli, 2002). In 1970 several articles presented
the antiviral and antibacterial activity of calcium
enolate (obtained by hydrolysis from oleuropein)
(Elliot et al., 1975; Soret, 1969). Subsequent
publications show that oleuropein also engages in
antimicrobial activity against viruses, retroviruses,
bacteria, yeasts, fungus, molds and other parasites
(Juven et al., 1972; Tassou and Nychas, 1995; Aziz
et al., 1998; Zanichelli et al., 2005). Other clinical
effects of oleuropein are the fortification of cellular
and organism protection through macrophage
response (Visioli et al., 1998), the inhibition of
plaque aggregation and eicosanoid production
(Petroni et al., 1995), and a reduction by nearly
30% in the level of low density lipoproteins (LDL)
(Visioli and Galli, 1994; Andrikopoulos et al., 2002).
2.2. Terpenic components
Vázquez-Roncero and Janer (1969) contributed
diverse qualitative results of the presence of terpenic
acids in the olive leaf. Later, Mussini et al. (1975)
isolated alpha-amyrine and confirmed the presence
of maslinic acid. Bianchi et al. (1993, 1994) analyzed
these compounds and some of those found by
Vázquez-Roncero and collaborators, in three Italian
varieties.
Among the terpenic compounds in the olive leaf,
one to take notice of is oleanolic acid (3-beta-
hydroxy-28-carboxyolean). This compound is found
extensively throughout the plant kingdom, and in the
olive leaf it occurs in free acid form in considerable
proportions, accounting for ≅ 3% of dry leaf weight
(Albi et al., 2001). Oleanolic acid is biologically active
with antiabortive, anti-cariogenic, anti-fertility, anti-
hepatotoxic, anti-inflammatory, antisarcomic, cancer-
preventive, cardiotonic, diuretic, hepatoprotective
and uterotonic properties. Numerous studies have
been published on the possible biological activity of
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this acid and its glucosides. It has been studied in its
activity as an inhibitor of the proliferation of leucemic
cells (Es-Saady et al., 1994), as a hypoglucemiant
(Yoshikawa et al., 1994), as an anti-tumoral agent
(Gerhauser et al., 2003), as a hepatoprotective agent
(Yim et al., 2001), as an anti-inflammatory (Ismaili et
al., 2002; Takeoka et al., 2000 and Choi et al., 2002),
as an anti-bacterial (Sasazuka et al., 1995), as an
inhibitor of the production of nitric acid (Honda et al.,
1997), as an anti-HIV agent (Mengoni et al., 2002), in
its anti-atherogenic activity (Somova et al., 2003) and
as a cardiotonic (Somova et al., 2004). Also in
existence are publications and patents for the
preparation of functional foods with oleanolic acid
(Hassel et al., 1998; Putte, 2000; Guinda et al., 2004).
2.3. Liposoluble compounds 
In 1973, Janer isolated by Thin Layer
Chromatography some liposoluble compounds
present in olive leaf extract (hexane extract) and
analyzed the fatty acids of the triacylglycerols from
leaves. In recent years, Guinda et al. (2002) have
isolated, identified and quantified numerous
components of a hexane extract of olive leaves,
consisting of: saturated hydrocarbons, squalene,
ester waxes, alpha-tocopherol, triglycerides, beta-
carotene, linear alcohols, alpha- and beta-amyrine,
and beta-sytosterol. These compounds have been
found in five Spanish varieties (Picual, Hojiblanca,
Empeltre, Arbequina and Cornicabra). The
concentration (ppm) of the compounds ranged from
the following: 050-3400 (saturated hydrocarbons),
38-152 (squalene), 915-1874, 28-100 (beta-
carotene), 832-1396 (triglycerides), 41-125 (alpha-
tocopherol), 714-2500 (beta- sytosterol), 95-311
(alcohols) and 342-837 (terpenic dialcohols). The
most numerous hydrocarbons in all of the varieties
studied are C29, C31 and C33. The waxes are
mainly constituted of fatty acids and the terpenic
alcohols of the olive leaf (palmitic, oleic, and linoleic;
alpha- and beta-amyrine). The terpenic dialcohols
found in the olive leaf are uvaol and erythrodiol, with
the uvaol content always higher than that of
erythrodiol, which is the opposite case in olive oil. A
large part of the compounds analyzed in the hexane
extract of the olive leaf, such as alpha-tocopherol,
beta-carotene, alpha- and beta-amyrine, squalene
and beta-sytosterol, are bioactive compounds
capable of modulating human physiological
systems. Therefore, these compounds have multiple
applications in the pharmaceutical, cosmetics and
food additives industries. Numerous articles have
been published on the antioxidant activity of alpha-
tocopherol, as well as on the protective effects of
alpha-tocopherol and of beta-carotene with regard
to atherogenesis (Devaraj et al., 1998) and cancer
(Virtamo et al., 2000; 2003). Other publications
examine the potential use of squalene (Kelly, 1999)
and its preventive effect on colon cancer (Newmark,
1999; Rao et al., 1998). Still others examine the
potential health benefits of the phytosterols: beta-
sytosterol reduces cholesterol levels in the blood, as
well as being effective at in vitro reduction of breast
cancer cells (Awad et al., 2001; 2003). Another area
of study has been the anti-inflammatory activity of
the triterpenic dialcohols of the olive leaf (alpha- and
beta-amyrine) (Martín-Cordero et al., 2001; Puerta
et al., 1997).
2.4. Other compounds 
The olive tree, like other members of the family of
Oleaceas, is distinguished by it capacity for the
biosynthesis of mannitol and oligosaccharides of the
rafinose family (raffinose and, above all, stachyose),
as well as sucrose, as direct products of
photosynthesis (Flora and Madore, 1993; Stoop et al.,
1996). Mannitol, a hexitol derivative of mannose,
offers a series of properties with advantageous
applications in the food and pharmaceutical
industries. Its sweetening potency is equivalent to
70% that of sucrose; it has a low caloric value (2
kcal/g), it does not cause caries and its metabolism in
humans is not dependent on insulin, which makes it
suitable for consumption by diabetics. Additionally, it
has healthful effects as an antioxidant (Wisselink et
al., 2002) and is of therapeutic use in severe head
injuries, as it is effective in the reduction of intracraneal
pressure (Brain Trauma Foundation, 1996; Filipo et al.,
1997; Unterberg et al., 1997). Its industrial preparation
is achieved by means of catalytic hydrogenation of
sugars. As this chemical process yields a scant
quantity of mannitol, in recent years research has
been conducted into alternative biotechnological
processes. The use of olive leaves as raw material in
obtaining mannitol offers a promising alternative, as
they contain between 10 and 20 mg per gram of plant
tissue of this carbohydrate (Flora and Madore, 1993;
Sánchez, 1998).
Recently, Campeol et al., 2004, have isolated
and identified through mass spectrometry (EIMS)
and nuclear magnetic resonance (H and C RMN), a
new compound: 1.5-Anhydroxylitol. This compound,
never before detected in the plant kingdom, was
obtained in the range of 0.1 to 1%.
For the purpose of obtaining basic data for the
processing and manufacture of foods, Ok-Hwan et
al. (2005) have analyzed the contents of the leaf as
to moisture, ash, crude protein, fat, carbohydrates,
the principal amino acids (glutamic and aspartic)
and principal free sugar (sucrose), as well as the
concentration of Ca and vitamins A and C. Neither
vitamins B6 nor B12 were detected.
3. USES OF OLIVE LEAVES 
3.1. The Benefits of extracts 
At present, there is a growing body of evidence
for the beneficial role that the phytonutrients play in
relation with the prevention of serious diseases
(Arai, 1997; Ovesen, 1997). The enormous interest
in these substances in recent years as additives or
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natural food ingredients has gone beyond food
preparation and conservation, into the new area
known as nutraceutics. This science studies the
therapeutic effects of the components of foods. It is
known that “functional foods” can modulate human
physiological systems, such as the immunological,
endocrinal, nervous, circulatory and digestive
systems, with this last a proven object of study
(Hassel, 1998). At present, several natural extracts,
among them that of the olive leaf, are used in the
manufacture of functional foods (Micol et al., 2003).
Diverse epidemiological studies have proven the
association between diets rich in antioxidant
compounds and a reduction in the risk of contracting
certain types of cancer, cardiovascular and ocular
diseases in which oxidative stress plays an important
part in their development (Garewall, 1997; Visioli et
al., 2000). As a result, nutritional recommendations
generally include the consumption of food and drink
rich in antioxidant compounds (Packer et al., 1999). It
is also becoming more frequent to design foods with
antioxidant functions (Hollingsworth, 1998). Among
the antioxidants present in the olive leaf, the phenolic
compounds are notable. Phenolic compounds are
one of the main products of the secondary
metabolism and comprise a wide range of structural
classes and biological functions.
Olive leaf extracts are well-known for their
antioxidant properties (Susnik-Rybarski, et al.,
1983; Benavente-García et al., 2000; Briante et al.,
2001; De la Fuente et al., 2005; Bouaziz and
Sayadi, 2005; Coll et al., 2000). Other significant
qualities associated with olive leaf extracts include
that of being a hypotensor (Khayyal et al., 2002), a
hypoglucemiant (Manceau et al., 1942; González et
al.,1992; Trovato et al., 1993; Komaki et al., 2003),
a hypocholesterolmiant (De Pasquale et al., 1991),
cardioprotective (Cicosta et al., 1990), radio-
protective (Benavente-García et al., 2002), anti-HIV
(Lee-Huang et al., 2003) and anti-viral (Micol et al.,
2003), antimutagenic (Yahiaoui et al., 1994),
anticarcinogenic (Pieroni et al., 1996; Onderoglu et
al., 1999; Hamdi and Castellon. 2005; Kosak and
Stern, 1962), hypotensive (Kosak and Stern, 1960),
and anti-inflammatory (Fehri et al., 1996). Of
special interest is the extract’s antimicrobial activity,
in the possibility of utilizing them as alternative food
additives (Markin et al., 2003; Tassou and Nychas,
1994). Similarly, various authors have reported on
the antibacterial activity of the phenolic compounds
of the olive tree (Tassou and Nychas, 1995; Tranter,
1993; Rodríguez et al., 1988; Paster et al., 1988;
Nychas et al., 1990). Other studies include one
conducted on the effect of an aqueous extract of
olive leaf on the thyroid gland in laboratory animals
(Al-Qarawi et al., 2002), and another on the
antioxidant activity of an olive leaf extract against
sunflower oil oxidation (Farag et al., 2002).
In the olive tree, phenolic compounds are more
abundant in the fruit than in the leaf; even so, they
are present in significant amounts (Le Tutour and
Guedon, 1992; Paiva-Martins and Gordon, 2001),
which makes utilization of the leaves worthwhile. In
addition, the leaf contains a considerable amount of
terpenic compounds, whose biological activity is
well-known. A specific review of the pharmacological
activity of oleanolic acid has been published (Tian et
al., 2002), as well as a study of the anticarcinogenic
effect of ursolic acid (Es-Saady et al., 1994, 1996a y
1996b). Basically, the leaf represents a by-product
whose potential for use is still under development. Its
use would facilitate the obtaining of natural products
at a competitive cost.
3.2. Uses of the extracts 
Up to now, use of the olive leaf has been made
principally through formulations which include an
extract of the same, without any previous separation
of the active compounds. There are numerous
preparations of this type on the market; they are used
as complements to the treatment of certain diseases
or as nutritional supplements. New patents appear
daily for functional foods or cosmetics based on olive
leaf extracts. The patents are quite varied in their
formulation; for example, there are liquid preparations
with alcohol and with glycerin (Oliveda Network SL,
2005 a y b). Equally diverse are the applications to
which these formulations are destined: manufacture
of dietetic bread for diabetics (Scheneder, 1985);
preparations which contain lycopene and olive leaf
extract for use in food or cosmetics (Coll et al., 1999);
use of olive leaf extracts in dietetic cookies (Shtukatur,
2003); the manufacture of a nutritional supplement
with physiological effects containing olive leaf extract
(Stueckler 1998); an extract of olive leaves to combat
free radicals, and their use in dietetic foods and in
cosmetics (Amari 1998).
4. OBTAINING HIGH ADDED-VALUE
COMPOUNDS FROM THE OLIVE LEAF 
Works on obtaining bioactive compounds from
the olive leaf are recent and not very numerous.The
techniques employed range from biotransformation
(Ryan et al., 2002; Verhe et al., 1992; Briante et al.,
2001), solid/liquid extraction and subsequent
fractionation of the extract (Albi et al., 2001), and
supercritical fluid extraction (SFE) (Lucas et al.,
2002; Tabera et al., 2004b).
Briante et al., (2001, 2002 and 2004) have
proposed a bioreactor for obtaining large quantities
of hydroxytyrosol of high purity (91-94% in weight),
starting from olive leaf extract. The process consists
of extraction with ethanol/water (1:1) from the leaf
and subsequent biotransformation of the extract, by
means of a hyperthermophilic beta-glucosidase,
partially purified and immobilized in a support of
chitosan (polysaccharide obtained from the shells of
crustaceans). The bioreactor is separated into two
chambers; the first column is filled with the matrix of
the chitosan enzyme and is used for the hydrolysis of
oleuropein into aglucone. The second column of the
bioreactor is used as a second reaction chamber at
high temperature and under pH-controlled
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conditions, permitting total hydrolysis of the
aglucone of oleuropein into hydroxytyrosol. Lucas et
al., (2002), obtain concentrates of alpha-tocopherol
directly from the leaves, by means of supercritical
fluid extraction (SFE). Tabera et al., (2004b), have
patented a process for obtaining high added-value
compounds from the olive leaf, consisting mainly of
a first stage of solid/liquid extraction with solvents
of decreasing polarity, and subsequent fine
fractionation of the different extracts through
extraction with supercritical CO2, in countercurrent
(CC-SFE). With this method they have obtained
concentrates of alpha-tocopherol (Tabera et al.,
2004a) and hydroxytyrosol, among others. Guinda
and colaborators, have developed a procedure for
obtaining terpenic acids from the leaves of Olea
europaea by means of extraction from the leaf with
an organic polar solvent, and separation of this acid
by crystallization. This patented process (Guinda et
al., 2000) allows for obtaining oleanolic acid with
approximately 93% purity. Subsequent purification
by means of a simple thermal treatment allows for
this acid to be obtained with a purity of 98-99%. The
advantage of this procedure is even greater when
taking into account that even though this triterpenic
acid is found extensively throughout the plant
kingdom, in the olive leaf, oleanolic acid occurs in
free acid form in considerable proportions (≅ 3% dry
leaf weight). Additionally, there is a considerable
amount of leaves available annually, when including
those coming from pruning and those separated
from the olives in the mills.
At the present time, is being investigated in the
Instituto de la Grasa (CSIC), (Spanish project AGL
2003-02795), a new and encouraging process that
involves a continuous separation procedure, by
means of molecular distillation (Short Path
Distillation), of the natural compounds present in
alcoholic olive leaf extract.
5. FINAL CONSIDERATIONS
To increase the economic performance of the
olive and related industries, it is of great importance
to make use of a by-product like the olive leaf.
Bioactive compounds obtained from the leaves
have dietetic, pharmaceutical and cosmetic
applications. Using this residue not only meets with
the requirement of its effective and innocuous
elimination: as well as preventing environmental
problems, it also creates new sources of wealth
which contribute to higher profitability in the initial
industrial process. Moreover, it should be taken into
account that making the management of residue
profitable generates all sorts of new industries, with
the resulting social gains.
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